pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,971 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: grant×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07530328: Clinical Evaluation of Copesilcup

    Sponsor: WMAS SpA. Phase: NA. Conditions: Catheter-Associated Infection

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06861465: eMPower Mechanisms

    Sponsor: University of Alberta. Phase: NA. Conditions: Primary Biliary Cholangitis (PBC)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03312465: Anatomical Shoulder Domelock System Study

    Sponsor: Zimmer Biomet. Phase: . Conditions: Avascular Necrosis, Revision Surgery, Conditions Consequent to Earlier Operations, Arthritis, Rheumatoid, Arthritis, Degenerative, Arthritis;Traumatic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07281365: Pilot Trial of an Emotion Regulation and Executive Functioning Intervention for Self-Injurious Thoughts and Behaviors (SITBs) in Children

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Self-injury, Suicidal Ideation and Behavior, Executive Functioning, Emotion Regulation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05414500: Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

    Sponsor: University of Alabama at Birmingham. Phase: PHASE1. Conditions: Cutaneous T Cell Lymphoma, Mycosis Fungoides

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07446400: A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

    Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07318688: Evaluate the Efficacy and Safety of HMI-115 in Women With Moderate to Severe Endometriosis-associated Pain

    Sponsor: Hope Medicine (Nanjing) Co., Ltd. Phase: PHASE3. Conditions: Endometriosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07594288: Baveno Classification Versus Polysomnography in Obstructive Sleep Apnea

    Sponsor: Hisar Intercontinental Hospital. Phase: . Conditions: Obstructive Sleep Apnea

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07356427: VR Tennis Training Effects on Psychological Outcomes

    Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Sports Performance, Psychological Adaptation

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04094961: Ixazomib + Pomalidomide + Dexamethasone In MM

    Sponsor: Omar Nadeem, MD. Phase: PHASE1. Conditions: Multiple Myeloma, Multiple Myeloma in Relapse

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06310161: Light Therapy in End Stage Kidney Disease

    Sponsor: University of Pennsylvania. Phase: NA. Conditions: End Stage Renal Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07533786: A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

    Sponsor: Haisco Pharmaceutical Group Co., Ltd.. Phase: PHASE2. Conditions: Pain After Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05124886: Gut Kidney Axis in Enteric Hyperoxaluria

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Enteric Hyperoxaluria

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07444970: Comparative Evaluation of Xenograft Alone and Sticky Bone in Sinus Lift With Concurrent Implant Placement

    Sponsor: Fayoum University. Phase: NA. Conditions: Sinus Lifting, Dental Implant, Sticky Bone

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07132073: MRI-guided Locoregional SBRT Prostate Program

    Sponsor: Clinica Universidad de Navarra, Universidad de Navarra. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06480773: Kaposi Sarcoma Chemotherapy and Research (KS-CARE)

    Sponsor: UNC Lineberger Comprehensive Cancer Center. Phase: . Conditions: Kaposi Sarcoma, HIV

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06131983: Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1

    Sponsor: Arrowhead Pharmaceuticals. Phase: PHASE1. Conditions: Facio-Scapulo-Humeral Dystrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02108041: Personalized Medicine Decision-Making in a Virtual Clinical Setting

    Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Deep Vein Thrombosis, Blood Clots

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06494254: Post-Operative Prediction of PulmonarY Function

    Sponsor: University of Sydney. Phase: . Conditions: Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07233954: Intraoperative Use of I.V. Sodium Fluorescein in Suspected CNS Tumors

    Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta. Phase: . Conditions: CNS

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07559305: A Theory-based Sleep Hygiene Education for Insomnia Patients

    Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Insomnia, Adults

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04963166: Natural History of Systemic and Nasal Mucosal Immunity After Influenza Vaccination in a Pediatric Population

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Influenza Immunity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07559266: BEYOND Study: Improving HIV Treatment and Well-Being Among Young MSM in Vietnam

    Sponsor: Center for Applied Research on Men and Community Health, Vietnam. Phase: . Conditions: HIV Infections, Mental Health, Medication Adherence

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07507656: The Effect of a Stress Ball Applied Before Retrograde Intrarenal Surgery on Anxiety, Surgical Fear, and Hemodynamic Parameters

    Sponsor: Mersin University. Phase: NA. Conditions: Anxiety, Fear

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07321002: PFLotus With the DePolar Mapping System in Patients With Persistent Atrial Fibrillation

    Sponsor: The Third People's Hospital of Chengdu. Phase: NA. Conditions: Persistent Atrial Fibrillation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04488302: Ultrasonography and Cone-Beam Computed Tomography for Peri-implant Tissue Evaluation

    Sponsor: University of Michigan. Phase: . Conditions: Ultrasonography

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07542002: Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors:A Prospective Exploratory Study

    Sponsor: Ningbo Medical Center Lihuili Hospital. Phase: PHASE2. Conditions: Pancreatic Cancer

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06423053: Mindfulness in a College Physiology Course

    Sponsor: Trustees of Dartmouth College. Phase: NA. Conditions: Mindfulness, Stress, Well-being

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05618353: The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

    Sponsor: VA Office of Research and Development. Phase: PHASE4. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06018337: A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

    Sponsor: DualityBio Inc.. Phase: PHASE3. Conditions: Metastatic Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07353437: Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)

    Sponsor: Fudan University. Phase: PHASE2. Conditions: Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07417345: Biomechanical Gait Analysis in Low Back Pain

    Sponsor: Arrate Pinto Carral. Phase: . Conditions: Low Back Pain

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07126275: Mirror Journaling App Study

    Sponsor: Child Mind Institute. Phase: NA. Conditions: Depression Symptoms, Anxiety Symptoms

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05435157: Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.

    Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León. Phase: . Conditions: Diabetes Mellitus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07517601: Erbium-doped Yttrium Aluminum Garnet (Er:YAG) Laser vs Conventional Ceramic Bracket Debonding: A Split-Mouth Clinical Trial

    Sponsor: Saint-Joseph University. Phase: NA. Conditions: Orthodontic Brackets, Pain, Temperature Change, Laser, Healthy Adult

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04709601: Efficacy and Mechanism of Action of Methenamine Hippurate (Hiprex™) in Women With Recurring Urinary Tract Infections.

    Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE4. Conditions: Urinary Tract Infections

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06540612: Effects of Aerobic Exercise on Cancer-Related Biomarkers, Functional Capacity, Cognitive Status and Quality of Life in Women With Breast Cancer

    Sponsor: Hasan Kalyoncu University. Phase: NA. Conditions: Breast Cancer Female, Quality of Life, Survivorship

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06545812: Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation

    Sponsor: Josip Juraj Strossmayer University of Osijek. Phase: NA. Conditions: Intervertebral Disc Herniation, Back Pain, Analgesic Nephropathy, Inflammatory Response

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04645212: Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

    Sponsor: Adverum Biotechnologies, Inc.. Phase: . Conditions: Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07539181: Disclosing Agents as Photosensitizers in aPDT for Biofilm Control in Children

    Sponsor: University of Nove de Julho. Phase: NA. Conditions: Dental Plaque

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07401719: Effects of Modified Clamshell Exercises in Patients With Hip Osteoarthritis Grade II.

    Sponsor: Lahore University of Biological and Applied Sciences. Phase: NA. Conditions: Osteo Arthritis of Hip

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06104228: 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

    Sponsor: Bastiaan Driehuys. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder), Connective Tissue Diseases

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07434128: Mammogram Pretreatment With Ulipristal Acetate

    Sponsor: OHSU Knight Cancer Institute. Phase: PHASE2. Conditions: Mammography Screening, Breast Density

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06797765: Optical Coherence Tomography Angiography in Neurological Disease

    Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Octa, Stroke, Subarachnoid Hemorrhage, Intracerebral Hemorrhage

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04375800: Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE2. Conditions: Human Immunodeficiency Virus (HIV) Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06271200: Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)

    Sponsor: National Health Research Institutes, Taiwan. Phase: NA. Conditions: Metabolic Syndrome

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05283200: Creating a Healthy L.I.F.E: Lifestyle Interventions For Epilepsy

    Sponsor: Imad Najm MD. Phase: NA. Conditions: Lifestyle

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03358303: Effects of Telemonitoring on the Outcome of Heart Failure Patients After an Incidence of Acute Decompensation

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Heart Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04844827: Pleural Carcinomatosis Tissue Banking

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Pleural Effusion, Malignant

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05245942: Monitoring of the Safety and the Performance of the Endoscopic Cap Electrode (ECE50)

    Sponsor: MED-EL Elektromedizinische Geräte GesmbH. Phase: . Conditions: Vocal Fold Paresis, Laryngeal Dystonia

    full page →ctgov ↗
    ← prev
    page 47 of 100
    next →